drugset / Trial / NCT00006037
Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
Phase 2
Terminated
18 enrolled
University of Southern California
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. IM-862 may stop the growth of colorectal cancer by stopping blood flow to the tumor. It is not yet known if chemotherapy is more effective with or without IM-862 in treating colorectal cancer. PURPOSE: Randomized phase II trial to study the effectiveness of chemotherapy plus IM-862 in treating patients who have metastatic colorectal cancer.
Timeline
- Start
- 1999-11
- Primary completion
- 2001-11
- Completion
- 2001-11
Outcome
Outcome not reported
Stopped: “Drug not available”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | — | Intravenous |
| Subject | fluorouracil | Small molecule | — | Intravenous |
| Subject | oglufanide | Small molecule | — | Intranasal |